UnitedHealth Group Incorporated (UNH)
NYSE: UNH · Real-Time Price · USD
321.56
-6.18 (-1.89%)
At close: Nov 6, 2025, 4:00 PM EST
318.79
-2.77 (-0.86%)
Pre-market: Nov 7, 2025, 6:50 AM EST
UnitedHealth Group Revenue
UnitedHealth Group had revenue of $113.16B in the quarter ending September 30, 2025, with 12.24% growth. This brings the company's revenue in the last twelve months to $435.16B, up 10.48% year-over-year. In the year 2024, UnitedHealth Group had annual revenue of $400.28B with 7.71% growth.
Revenue (ttm)
$435.16B
Revenue Growth
+10.48%
P/S Ratio
0.67
Revenue / Employee
$1,087,898
Employees
400,000
Market Cap
291.28B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 400.28B | 28.66B | 7.71% |
| Dec 31, 2023 | 371.62B | 47.46B | 14.64% |
| Dec 31, 2022 | 324.16B | 36.57B | 12.71% |
| Dec 31, 2021 | 287.60B | 30.46B | 11.84% |
| Dec 31, 2020 | 257.14B | 14.99B | 6.19% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
| Abbott Laboratories | 43.84B |
UNH News
- 1 day ago - UnitedHealth Group: Absorbing Cost-Pressures Is A Key Competitive Advantage - Seeking Alpha
- 1 day ago - Buy Or Sell United Health Stock? - Forbes
- 2 days ago - UnitedHealth: The Market Is Still Worried, And That's Good For Buyers - Seeking Alpha
- 3 days ago - UnitedHealth Group Q3: Why Strong Money Holds At $323 - Seeking Alpha
- 3 days ago - UnitedHealth: A Glimmer Of Future Growth Is Still There - Seeking Alpha
- 7 days ago - UNH - 3 Reasons Not To Buy After 'Beat & Raise' - Seeking Alpha
- 8 days ago - UnitedHealth: Risk-Reward Profile Signals Time To Hold, Not Buy (Rating Downgrade) - Seeking Alpha
- 8 days ago - Heard on the Street: UnitedHealth and CVS are pruning their Medicare Advantage businesses to favor profit over size - WSJ